Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic antiemetic efficacy of ramosetron vs ondansetron in postoperative patients using IV PCA
KCT0001499Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramosetron, ondansetron in postoperative nausea and vomiting (PONV), sponsored by Astellas Pharma. Started Nov 2010; status: completed.
02
Drugs
ramosetronondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on KCT0001499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001499.